Covidien Ltd Company Profile (NYSE:COV)

About Covidien Ltd

Covidien Ltd logoCovidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Health Care Equipment & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: COV
  • CUSIP: G2554F11
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $0
  • 200 Day Moving Average: $0
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0
  • Market Cap: $N/A
Additional Links:
Companies Related to Covidien Ltd:

Analyst Ratings

Consensus Ratings for Covidien Ltd (NYSE:COV) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Covidien Ltd (NYSE:COV)
DateFirmActionRatingPrice TargetDetails
11/6/2014Jefferies GroupReiterated RatingBuy$96.00 -> $107.00View Rating Details
(Data available from 10/23/2014 forward)


Earnings History for Covidien Ltd (NYSE:COV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/22/2015Q115$1.05$1.12$2.72 billion$2.69 billionViewN/AView Earnings Details
11/5/2014Q414$1.02$1.15$2.69 billion$2.73 billionViewListenView Earnings Details
7/25/2014Q314$1.00$1.04$2.69 billion$2.69 billionViewListenView Earnings Details
4/25/2014Q214$0.95$0.96$2.61 billion$2.60 billionViewListenView Earnings Details
1/24/2014Q114$0.94$1.00$2.61 billion$2.64 billionViewListenView Earnings Details
11/8/2013Q413$0.90$0.91$2.56 billion$2.56 billionViewListenView Earnings Details
8/1/2013Q3 2013$0.89$0.85$2.58 billion$2.58 billionViewListenView Earnings Details
4/26/2013Q2 2013$1.09$1.12$3.12 billion$3.10 billionViewListenView Earnings Details
1/25/2013Q1 2013$1.06$1.10$3.00 billion$3.06 billionViewListenView Earnings Details
11/9/2012Q412$1.00$1.02$2.98 billion$3.00 billionViewN/AView Earnings Details
7/26/2012$1.06$1.07ViewN/AView Earnings Details
4/27/2012$1.03$1.05ViewN/AView Earnings Details
1/26/2012$1.03$1.13ViewN/AView Earnings Details
11/15/2011$1.05$1.08ViewN/AView Earnings Details
7/26/2011$0.94$1.01ViewN/AView Earnings Details
4/21/2011$0.89$0.93ViewN/AView Earnings Details
2/1/2011$0.81$0.95ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Covidien Ltd (NYSE:COV)
Current Year EPS Consensus Estimate: $0.00 EPS
Next Year EPS Consensus Estimate: $0.00 EPS


Current Dividend Information for Covidien Ltd (NYSE:COV)
Annual Dividend:$0.00
Dividend Yield:0.00%
Dividend Growth:-33.00% (3 Year Average)
Payout Ratio:NaN (Based on Current Year Consensus EPS Estimate)
NaN (Based on Next Year Consensus EPS Estimate)
Track Record:7 Years of Consecutive Dividend Growth

Dividend History for Covidien Ltd (NYSE:COV)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Covidien Ltd (NYSE:COV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/5/2014Michael SgrignariSVPSell25,795$103.48$2,669,266.60View SEC Filing  
12/3/2014Dennis H ReilleyDirectorSell10,521$101.39$1,066,724.19View SEC Filing  
11/17/2014Richard G Brown JrVPBuy5,300$94.44$500,532.00View SEC Filing  
11/7/2014Robert H BrustDirectorSell4,000$92.03$368,120.00View SEC Filing  
8/27/2014Coleman N Lannum IIIVPBuy3,338$87.23$291,173.74View SEC Filing  
8/26/2014Coleman N Lannum IIIVPBuy1,736$87.46$151,830.56View SEC Filing  
8/19/2014Coleman N Lannum IIIVPBuy1,720$87.82$151,050.40View SEC Filing  
8/18/2014Coleman N Lannum IIIVPBuy4,100$87.58$359,078.00View SEC Filing  
6/16/2014Jose E AlmeidaInsiderSell51,166$92.05$4,709,830.30View SEC Filing  
4/29/2014Brian Douglas KingVPSell15,569$70.11$1,091,542.59View SEC Filing  
3/28/2014Charles DockendorffCFOSell90,730$72.50$6,577,925.00View SEC Filing  
2/28/2014Jose AlmeidaInsiderSell50,000$72.00$3,600,000.00View SEC Filing  
2/13/2014Richard Brown, Jr.VPSell4,000$71.00$284,000.00View SEC Filing  
2/11/2014Brian Douglas KingVPSell17,946$70.00$1,256,220.00View SEC Filing  
2/11/2014Bryan HansonSVPSell32,480$69.97$2,272,625.60View SEC Filing  
1/29/2014Coleman Lannum IIIVPSell13,787$69.23$954,474.01View SEC Filing  
1/24/2014Richard Brown, Jr.VPSell4,000$70.00$280,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Covidien Ltd (NYSE:COV)
DateHeadline logoBaxter names former Covidien chief José Almeida CEO (NYSE:COV) - October 23 at 8:59 AM logoU.S. top court rejects Covidien bid to restore patent verdict against Ethicon (NYSE:COV) - October 23 at 8:59 AM logoMedical device maker Medtronic's profit beats estimates (NYSE:COV) - October 23 at 8:59 AM logoMedtronic Notches Strong Quarter Despite FX Headwinds (NYSE:COV) - October 23 at 8:59 AM logoMedtronic Beats Q2 Earnings, Covidien Integration on Track (NYSE:COV) - October 23 at 8:59 AM logoMedtronic's Overseas Tax Move Freed Up $9.3 Billion (NYSE:COV) - October 23 at 8:59 AM logoDividend Aristocrats Part 27: Medtronic PLC (MDT) (NYSE:COV) - October 23 at 8:58 AM logoMedtronic PLC (MDT): Double-Digit Dividend Growth for this Dividend Aristocrat (NYSE:COV) - October 23 at 8:58 AM logoTyco's Tax Avoidance Machine Will Outlive Its Infamous Name (NYSE:COV) - October 23 at 8:58 AM logoMedtronic (MDT) to Report Q3 Earnings: What's in the Cards? (NYSE:COV) - October 23 at 8:58 AM logoMedtronic Is Buying Its Way to Better Stock Health (NYSE:COV) - October 23 at 8:58 AM logoMedtronic Earnings: Recently Launched Products And Covidien Revenues Help Post Strong Quarter (NYSE:COV) - October 23 at 8:58 AM logoWhat’s Medtronic’s Plan to Use Its Increased Cash Accessibility? (NYSE:COV) - October 23 at 8:58 AM logoCovalon Technologies Ltd. :COV-CA: Earnings Analysis: Q2, 2016 By the Numbers : June 7, 2016 (NYSE:COV) - October 23 at 8:58 AM logoGabelli Funds Comments on Medtronic Plc (NYSE:COV) - October 23 at 8:58 AM logoPhilips Healthcare, Medtronic Projected to Increase their Market Share Despite Competition and Reduced Healthcare Budgets (NYSE:COV) - October 22 at 4:11 PM
News IconGastrointestinal Endoscopic Devices Market will Grow at a CAGR of 7.0% during 2015 and 2021 (NYSE:COV) - October 22 at 4:11 PM logoNon-Invasive Brain Trauma Monitoring Devices Market Is Expected To Generate Huge Profits by 2020 (NYSE:COV) - October 19 at 9:19 AM
News IconNuclear Cardiology Market to Maintain Healthy CAGR in Coming Years, 2015 – 2021 (NYSE:COV) - October 17 at 9:22 AM
News IconThermal Ablation Devices Market: Opportunities and Forecasts, 2016 – 2024 (NYSE:COV) - October 14 at 9:52 AM logoBariatric Surgery Market to grow at a CAGR of 8.4% over the period 2015 to 2021 (NYSE:COV) - October 10 at 4:12 PM
News IconEurope Choledochoscope Market Report 2016 (NYSE:COV) - October 8 at 9:03 AM logoSafety Syringes Market is Estimated at USD 4620 Million in 2016 and is Predicted to Reach USD 7095 Million by 2021 (NYSE:COV) - October 7 at 4:17 PM
News IconDisposable Syringes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 (NYSE:COV) - October 5 at 9:32 AM
News IconRecent research: Syringes market report forecasts healthy growth by 2022 (NYSE:COV) - October 4 at 9:13 AM logoSyringes Market Report Forecasts Healthy Growth by 2022 - Scalar Market Research (NYSE:COV) - October 4 at 9:13 AM
News IconNebulizers Market to Reach USD 890 Million by 2020, Published by iHealthcareAnalyst, Inc. (NYSE:COV) - October 1 at 9:50 AM
News Icon2021 Global Endoscopic Accessories Market Forecast Report (NYSE:COV) - October 1 at 9:50 AM logoGlobal Pressure Relief Device Market By Product Type, 2014 and 2020 (NYSE:COV) - September 30 at 4:47 PM
News IconHypodermic Needles Market by Segmentation (safety and non-safety needles), 2021 (NYSE:COV) - September 30 at 4:47 PM
News IconIncidences of Road Accidents and Sports Related Injuries Drives Surgical Dressings Market (NYSE:COV) - September 28 at 4:15 PM
News IconAcute Ischemic Stroke Diagnosis and Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 (NYSE:COV) - September 27 at 4:20 PM logoGlobal Gastrointestinal Endoscopic Devices market revenue, 2015 - 2021 (NYSE:COV) - September 27 at 8:59 AM
News IconGlobal Neurovascular Market 2016 – Opportunities and Forecasts to 2022 (NYSE:COV) - September 23 at 9:29 AM
News IconGlobal Electrosurgical Devices Market 2016: Industry Demand, Consumption and Research to 2021 (NYSE:COV) - September 22 at 9:58 AM
News IconGastrointestinal Endoscopic Devices Market Share, By Type, 2015 and 2021 (NYSE:COV) - September 22 at 9:58 AM logoPortable Medical Electronic Products Global Market Expected to Grow at 4.21% CAGR by 2022 (NYSE:COV) - September 21 at 8:36 AM
News IconTracheal Tubes and Airway Products Market with Worldwide Industry Analysis to 2025 (NYSE:COV) - September 15 at 4:44 PM
News IconGlobal Non-Invasive Brain Trauma Monitoring Devices Market Opportunities and Forecasts, 2020 (NYSE:COV) - September 15 at 4:44 PM logoMedical Adhesives Market Shareto Reach $14.2 billion with 10.7% CAGR Forecast to 2022 (NYSE:COV) - September 14 at 4:26 PM
News IconGlobal ablation devices sales industry forecast to 2021 with key companies profile, supply, demand, cost structure, and SWOT analysis just published (NYSE:COV) - September 6 at 9:15 AM
News IconGastrointestinal Endoscopic Devices Market set to reach USD 8.5 Billion by 2021 (NYSE:COV) - September 6 at 9:15 AM logoTumour Ablation Devices World Market Segmentation and Major Players Analysis 2022 (NYSE:COV) - September 4 at 4:06 PM logoGastrointestinal Endoscopic Devices Market will reach USD 8.5 Billion by 2021, Globally (NYSE:COV) - September 4 at 4:06 PM
News IconResearch details developments in the tumour ablation devices - global market outlook (2015-2022) (NYSE:COV) - September 3 at 8:59 AM
News IconCanada Disposable Hospital Supplies Market Outlook to 2021 (NYSE:COV) - September 2 at 4:08 PM logoContinuous Renal Replacement Therapy (CRRT) World Market Segmentation and Major Players Analysis 2022 (NYSE:COV) - September 2 at 4:08 PM logoPortable Medical Electronic Products Market to Reach $73.95 billion with 4.21% CAGR Forecast to 2022 (NYSE:COV) - September 2 at 4:08 PM logoDisposable Incontinence Products Market to register a healthy CAGR for the forecast period, 2016-2026 (NYSE:COV) - September 1 at 10:58 AM
News IconGastrointestinal Endoscopic Devices Market: growing at a CAGR of around 7.0% between 2016 and 2021 (NYSE:COV) - August 31 at 4:19 PM


Covidien Ltd (NYSE:COV) Chart for Sunday, October, 23, 2016

Last Updated on 10/23/2016 by Staff